Dublin, Feb. 07, 2017 -- Research and Markets has announced the addition of the "Cell Analysis Global Market - Forecast to 2023" report to their offering.
The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023.
The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market.
North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the cell analysis market. Drug discovery services outsourcing and government funding for novel screening technologies have resulted in a growth of Asian markets.
The key players in the cell analysis global market include
- Agilent Technologies, Inc. (U.S.)
- Becton Dickinson and Company (U.S.)
- Bio-Rad Laboratories (U.S.)
- Danaher Corporation (U.S.)
- GE Healthcare (U.K.)
- Merck KGAA (Germany)
- Olympus Corporation (Japan)
- PerkinElmer, Inc. (U.S.)
- Promega Corporation (U.S.)
- Qiagen N.V. (Netherlands)
- ThermoFisher Scientific, Inc. (U.S.).
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.4 Regulatory Affairs
3.5 Porter's Five Force Analysis
3.6 Latest and Upcoming Products
3.7 Ongoing Researches and Funding Scenario
3.8 Supply Chain Analysis
3.9 Live Cell Imaging
3.10 Market Share Analysis
4 Cell Analysis Global Market, by Techniques
4.1 Introduction
4.2 Molecular Approaches
4.3 Image Based Approaches
5 Cell Analysis Global Market, by Products
5.1 Introduction
5.2 Consumables
5.3 Instruments
5.4 Softwares and Services
6 Cell Analysis Global Market, by Application
6.1 Introduction
6.2 Cell Analysis Global Market, by Process of Application
6.3 Cell Analysis Global Market, by Field of Application
6.4 Cell Analysis Global Market, by Therapeutic Area Of Applications
7 Cell Analysis Global Market, by End-Users
7.1 Introduction
7.2 Hospitals
7.3 Academic & Research Laboratories
7.4 Diagnostic Laboratories
7.5 Pharmaceuticals and Biotech Companies
7.6 Contract Research Organisations
7.7 Cell Banks
7.8 Others
8 Regional Market Analysis
9 Company Developments
9.1 Introduction
9.2 New Product Launch
9.3 Agreements Parterner Ships, Collaborations & Joint Ventures
9.4 Mergers and Acquisitions
9.5 Approval
9.6 Business Expansion
10 Major Player Profiles
For more information about this report visit http://www.researchandmarkets.com/research/gjqjs5/cell_analysis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 



